Clinical trial · Interventional
Ghrelin - A Possible Opportunity to Improve Appetite
Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss
NCT00681486CI-TRIAL-00002564Phase 3completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ghrelin | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- A, 1
- description
- Ghrelin
- interventionNames
- Drug: Ghrelin
- type
- ACTIVE_COMPARATOR
- label
- A, 2
- description
- Ghrelin.
- interventionNames
- Drug: Ghrelin
Primary outcomes (1)
- measure
- Food intake
- timeFrame
- June 2008
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Weight loss Exclusion Criteria: * Diabetes
References
Publications (0)
Data not yet available
No reference posted for this study.